The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Obstacles to achieving a cure in CLL
Nicholas Chiorazzi, MD, Feinstein Institute for Medical Research, Manhasset, NY, discusses the possibility of achieving a cure in chronic lymphocytic leukemia (CLL). Whilst novel agents have been shown to lead to long-term remissions, it is critical to better manage side effects as it is an important cause for treatment discontinuation. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
